Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail

VANCOUVER, BC / ACCESSWIRE / March 16, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that industry veteran Jenna Pozar is joining the team as Chief Operating Officer. Mrs. Pozar brings 18 years of experience working in the natural healthcare products space, and will head up Havn Retail's sales, marketing, e-commerce and logistics efforts.

As the founder and owner of Pozar Health Solutions, Pozar has built Western Canada's fastest growing sales and management agency in the natural health space. Pozar Health Solutions serves a diverse roster of clients, offering premium natural health products, retail insights, and business-to-business consulting services. Mrs. Pozar has also worked for Jamieson Labs and Body Plus, where she was responsible for growth and planning for 200+ retail store accounts and three national chains, with a portfolio of eight natural health and performance brands.

"I'm thrilled to join Havn Life and look forward to leveraging my expertise in natural health products to help ensure a successful launch for the Havn Retail product line. It's an honor to join such an experienced team, particularly at this exciting moment in the company's growth," commented Ms. Pozar.

The Havn Retail product line will launch this spring at Nesters Market and other retail locations, with a Havn Life e-commerce site set to follow.

On Behalf of The Board of Directors

Tim Moore
Chief Executive Officer

About Havn Life Sciences Inc.

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram, and Youtube.

Contact:

Investor Relations: [email protected], 604-687-7130
Media: [email protected], 647-896-8078

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this news release, including statements which may contain words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions, and statements related to matters which are not historical facts, such as statements regarding the contemplated completion of the Acquisition, are forward-looking information within the meaning of applicable securities laws. Such forward-looking statements reflect management's expectations and are based on certain factors and assumptions and involve known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements. These factors should be considered carefully, and readers should not place undue reliance on the Company's forward-looking statements. The Company believes that the expectations reflected in the forward-looking statements contained in this news release are reasonable, but no assurance can be given that these expectations will prove to be correct, nor that the Acquisition will be completed as contemplated, or at all. The Company undertakes no obligation to release publicly any future revisions to forward-looking statements to reflect events or circumstances after the date of this news or to reflect the occurrence of unanticipated events, except as expressly required by law.

The CSE has not reviewed, approved or disapproved the content of this press release

SOURCE: Havn Life Sciences Inc.